The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAPE.L Regulatory News (KAPE)

  • There is currently no data for KAPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes including appointment of CEO

31 May 2016 07:00

RNS Number : 6432Z
Crossrider plc
31 May 2016
 

Crossrider plc

 

("Crossrider" or the "Group")

 

Board Changes including appointment of CEO

 

Crossrider (AIM:CROS), the creator of digital advertising platforms specialising in monetising web and mobile media through the use of big data, announces the following changes to its Board.

 

Ido Erlichman, has been appointed Group Chief Executive Officer with immediate effect. Ido has more than nine years' experience in the technology sector garnered through roles in private equity, consulting and finance. Prior to joining Crossrider, Ido was acting Joint Chief Executive Officer of VisualDNA*, a leading psychographic data business, where he led its geographic expansion and oversaw significant EBITDA growth.Previously, he also worked as a Senior Associate within KPMG's Private Equity deal advisory practice in London; as a Senior Manager within KPMG's Transaction Services practice focusing on technology deals in Israel; and with the Israeli Ministry of Finance. Ido is Certified Public Accountant, graduated magna cum laude in Accounting and Economics from The Hebrew University of Jerusalem, obtained his Masters degree in Law from Bar-Ilan University, and received an MBA from the University of Cambridge's Judge Business School. VisualDNA is ultimately owned by a trust, the sole beneficiary of which is Teddy Sagi.

 

Following the appointment of a chief executive, Don Elgie's role has reverted to that of Non-Executive Chairman.

 

In addition to the changes above, the Group announces that Mark Carlisle, Chief Financial Officer, has given notice of his intention to resign from his position in order to join another listed company as Chief Financial Officer.

 

Mark will remain with the Group to ensure an orderly handover of his responsibilities and has, therefore, agreed that he will leave his post on 19 August 2016. A search for a new CFO is already underway and a further update will be provided in due course.

 

Commenting on the Board changes, Crossrider's Chairman, Don Elgie, said:

 

"I am delighted to welcome Ido to the Board. Ido brings the required technology credentials and M&A experience from his previous roles, in particular, VisualDNA and KPMG. The Board conducted a thorough strategic search process, including both external and internal candidates and believes Ido has the necessary qualities to take Crossrider to the next phase of its development. I have every confidence in Ido's ability to lead the Group, direct our M&A strategy and lead engagement with our financial stakeholders.

 

"On behalf of the Board, I would like to thank Mark for his contribution since he joined in 2014. He leaves with our best wishes as he embarks on the next stage of his career."

 

*VisualDNA is the trading name of Imagini Europe Limited.

 

 

- Ends -

 

For further information contact:

 

Crossrider plc

Don Elgie, Executive Chairman

Mark Carlisle, Chief Financial Officer

 

+44 (0) 20 3772 2496

via Bell Pottinger

Bell Pottinger

David Rydell

James Newman

Sam Cartwright

 

+44 (0) 20 3772 2496

Shore Capital

Bidhi Bhoma

Toby Gibbs

 

+44 (0) 20 7408 4090

Disclosures pursuant to Schedule 2(g) of the AIM Rules

 

Mr. Erlichman's full name is Ido Erlichman, he is 35 years old.

 

Mr. Erlichman is currently a director of:

RedZone Empire Limited

 

In the past five years he has been a director of:

Imagini Europe Limited, trading as VisualDNA

Duvdevan Association

 

Mr. Erlichman does not hold any other directorships or partnerships.

 

There are no other disclosures required relating to Mr. Erlichman's appointment in accordance with Schedule 2(g) of the AIM Rules.

 

About Crossrider

 

Crossrider is a creator of digital advertising platforms specialising in monetising web and mobile media through the use of big data. The Company's web and mobile platforms power ad networks, agencies and direct publishers and enable the delivery of relevant digital advertising through the analysis of big data: making online marketing significantly more efficient and cost effective.

 

The Group operates web and mobile platforms which generate big data, enabling the development of a proprietary ad serving algorithm and engine that can extract value from this data to deliver relevant advertising to targeted users.

 

Crossrider's vision is to become the de facto standard platform for delivering relevant web and mobile adverts to billions of people, powering the next generation of digital advertising.

 

www.crossrider.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADDGDUUDXBGLG
Date   Source Headline
31st May 20237:00 amRNSCancellation - KAPE TECHNOLOGIES PLC
24th May 20239:07 amRNSHolding(s) in Company
22nd May 20237:00 amRNSHolding(s) in Company
22nd May 20237:00 amRNSOffer Closure and Acceptance Level Announcement
18th May 20231:06 pmRNSHolding(s) in Company
17th May 20233:04 pmRNSHolding(s) in Company
10th May 20238:50 amRNSHolding(s) in Company
9th May 20237:00 amRNSAcceptance Level Announcement
5th May 20233:02 pmRNSHolding(s) in Company
5th May 20239:17 amRNSHolding(s) in Company
3rd May 20237:00 amRNSForm 8 (DD) - Kape Technologies Plc
2nd May 20237:50 amRNSAcceptance Level Announcement
28th Apr 20238:31 amGNWForm 8.5 (EPT/RI) - Kape Technologies Plc
28th Apr 20237:00 amRNSFinal Cash Offer declared unconditional
27th Apr 20236:20 pmRNSNotice Of Offer Closure And Delisting From AIM
27th Apr 20235:30 pmRNSKape Technologies
27th Apr 20235:20 pmRNSRule 2.9 Announcement
27th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Kape Technologies plc
27th Apr 20239:29 amRNSForm 8.5 (EPT/RI)
27th Apr 20239:27 amRNSForm 8 (DD) - Kape Technologies Plc
27th Apr 20238:31 amGNWForm 8.5 (EPT/RI) - Kape Technologies Plc
26th Apr 20236:26 pmRNSIncreased And Final Offer Declared Unconditional
26th Apr 20233:25 pmRNSHolding(s) in Company
26th Apr 202311:01 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Kape Technologies plc
26th Apr 20237:11 amRNSUpdate on Increased and Final Offer
26th Apr 20237:00 amRNSForm 8 (DD) - Kape Technologies Plc
25th Apr 20231:52 pmRNSPublication of Second Response Document
25th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Kape Technologies plc
25th Apr 202311:46 amRNSHolding(s) in Company
25th Apr 202311:43 amRNSHolding(s) in Company
25th Apr 202310:59 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Kape Technologies plc
25th Apr 20238:20 amGNWForm 8.5 (EPT/RI) - Kape Technologies Plc
25th Apr 20237:00 amRNSAcceptance Level Announcement
24th Apr 20233:00 pmBUSForm 8.3 - KAPE LN
24th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Kape Technologies plc
24th Apr 202310:56 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Kape Technologies plc
24th Apr 202310:36 amRNSForm 8 (DD) - Kape Technologies Plc
21st Apr 20236:05 pmRNSFurther Update on Increased and Final Offer
21st Apr 20233:21 pmRNSResponse to Revised and Final Cash Offer
21st Apr 20233:00 pmBUSForm 8.3 - KAPE LN
21st Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Kape Technologies plc
21st Apr 202311:16 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Kape Technologies plc
21st Apr 202310:21 amRNSPosting Of Revised Offer Document
21st Apr 20239:25 amRNSUpdate on Increased and Final Offer
21st Apr 20237:58 amGNWForm 8.5 (EPT/RI) - Kape Technologies Plc
20th Apr 202310:21 amRNSForm 8.5 (EPT/RI)
20th Apr 20238:03 amRNSResponse to Revised and Final Cash Offer
20th Apr 20237:54 amGNWForm 8.5 (EPT/RI) - Kape Technologies Plc
20th Apr 20237:00 amRNSCash Offer Increased And Declared Final
19th Apr 202311:51 amRNSRule 2.9 Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.